固定低剂量三联降压药对比常规治疗对斯里兰卡轻中度高血压患者的血压控制:一项随机临床试验
该随机开放标签试验纳入斯里兰卡700例需起始或升级降压治疗的轻中度高血压患者,比较每日一次固定低剂量三联药(替米沙坦20mg+氨氯地平2.5mg+氯噻酮12.5mg)与常规治疗。6个月时三联药组达标率70% vs 常规组55%(风险差12.7%,95%CI 3.2-22.0,P<.001),平均血压降幅更大,因不良事件停药率无显著差异。
要点
- 固定低剂量三联药6个月血压达标率70%,显著高于常规治疗的55%。
- 三联药组6个月平均血压125/76 mmHg,常规组134/81 mmHg。
- 因不良事件停用降压药比例两组相似(6.6% vs 6.8%)。
核心结论
- 在轻中度高血压患者中,使用含三种降压药低剂量的单片复方制剂较常规治疗可提高血压达标比例。
研究设计与样本
- 随机、开放标签试验,纳入斯里兰卡11家城市医院门诊的700例高血压患者(平均年龄56岁,58%女性,29%糖尿病,基线平均血压154/90 mmHg),随机分为固定低剂量三联药组(n=349)和常规治疗组(n=351),随访6个月。
主要发现
- 6个月时三联药组达标率70%,常规组55%,风险差12.7%(95%CI 3.2%至22.0%,P<.001)。
- 6个月时平均血压三联药组125/76 mmHg,常规组134/81 mmHg;随访期间收缩压调整差-9.8 mmHg(95%CI -7.9至-11.6),舒张压-5.0 mmHg(95%CI -3.9至-6.1),均P<.001。
- 255例患者共报告419例不良事件(三联药组38.1% vs 常规组34.8%),最常见为肌肉骨骼疼痛(6.0% vs 8.0%)和头晕、晕厥前兆或晕厥(5.2% vs 2.8%)。
- 因不良事件停用降压治疗的比例两组无显著差异(三联药组6.6% vs 常规组6.8%)。
关键数值与推荐
- 主要终点为6个月时达到目标血压(<140/90 mmHg,糖尿病或慢性肾病患者<130/80 mmHg)的比例。
- 三联药单片复方制剂每日一次,含替米沙坦20 mg、氨氯地平2.5 mg和氯噻酮12.5 mg。
临床怎么用
- 对于轻中度高血压需起始或升级治疗的患者,可考虑将低剂量三联单片复方制剂作为初始治疗或替代单药治疗以改善血压控制。
局限性
- 开放标签设计可能引入偏倚;试验仅在斯里兰卡城市医院门诊进行,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Poorly controlled hypertension is a leading global public health problem requiring new treatment strategies. OBJECTIVE: To assess whether a low-dose triple combination antihypertensive medication would achieve better blood pressure (BP) control vs usual care. DESIGN, SETTING, AND PARTICIPANTS: Randomized, open-label trial of a low-dose triple BP therapy vs usual care for adults with hypertension (systolic BP >140 mm Hg and/or diastolic BP >90 mm Hg; or in patients with diabetes or chronic kidney disease: >130 mm Hg and/or >80 mm Hg) requiring initiation (untreated patients) or escalation (patients receiving monotherapy) of antihypertensive therapy. Patients were enrolled from 11 urban hospital clinics in Sri Lanka from February 2016 to May 2017; follow-up ended in October 2017. INTERVENTIONS: A once-daily fixed-dose triple combination pill (20 mg of telmisartan, 2.5 mg of amlodipine, and 12.5 mg of chlorthalidone) therapy (n = 349) or usual care (n = 351). MAIN OUTCOMES AND MEASURES: The primary outcome was the proportion achieving target systolic/diastolic BP (<140/90 mm Hg or <130/80 mm Hg in patients with diabetes or chronic kidney disease) at 6 months. Secondary outcomes included mean systolic/diastolic BP difference during follow-up and withdrawal of BP medications due to an adverse event. RESULTS: Among 700 randomized patients (mean age, 56 years; 58% women; 29% had diabetes; mean baseline systolic/diastolic BP, 154/90 mm Hg), 675 (96%) completed the trial. The triple combination pill increased the proportion achieving target BP vs usual care at 6 months (70% vs 55%, respectively; risk difference, 12.7% [95% CI, 3.2% to 22.0%]; P < .001). Mean systolic/diastolic BP at 6 months was 125/76 mm Hg for the triple combination pill vs 134/81 mm Hg for usual care (adjusted difference in postrandomization BP over the entire follow-up: systolic BP, -9.8 [95% CI, -7.9 to -11.6] mm Hg; diastolic BP, -5.0 [95% CI, -3.9 to -6.1] mm Hg; P < .001 for both comparisons). Overall, 419 adverse events were reported in 255 patients (38.1% for triple combination pill vs 34.8% for usual care) with the most common being musculoskeletal pain (6.0% and 8.0%, respectively) and dizziness, presyncope, or syncope (5.2% and 2.8%). There were no significant between-group differences in the proportion of patient withdrawal from BP-lowering therapy due to adverse events (6.6% for triple combination pill vs 6.8% for usual care). CONCLUSIONS AND RELEVANCE: Among patients with mild to moderate hypertension, treatment with a pill containing low doses of 3 antihypertensive drugs led to an increased proportion of patients achieving their target BP goal vs usual care. Use of such medication as initial therapy or to replace monotherapy may be an effective way to improve BP control. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12612001120864; slctr.lk Identifier: SLCTR/2015/020.
引用
- Webster R, Salam A, de Silva HA, et al. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial. JAMA. 2018. PMID: 30120478. doi:10.1001/jama.2018.10359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。